Extracellular matrix proteins as risk markers for complications in type 1 diabetes.

Authors

Marte Opseth Rygg, Alexandra Louise Møller, Viktor Rotbain Curovic, Daniel Guldager Kring Rasmussen, Simone Theilade, Nete Tofte, Signe Abitz Winther, Federica Genovese, Morten Aasser Karsdal, Thomas Kümler, Tine Willum Hansen, Peter Rossing

Published in

Diabetic medicine : a journal of the British Diabetic Association. Pages e70396. Jun 20, 2026. Epub Jun 20, 2026.

Abstract

Kidney fibrosis, characterised by impaired extracellular matrix remodelling and excessive collagen deposition, is a hallmark of chronic kidney disease in diabetes. We investigated whether biomarkers reflecting collagen formation and degradation were associated with complications in type 1 diabetes.
In this observational cohort study, markers of collagen type III (PRO-C3), VII (PRO-C7) and XXVIII (PRO-C28) formation and collagen type III degradation (CTX-III) were measured in serum by ELISA. Associations between baseline biomarker levels and a composite kidney endpoint, all-cause mortality, albuminuria progression and cardiovascular events were tested using Cox proportional hazards models adjusted for traditional risk factors. Hazard ratios (HRs) are reported per 1-SD increase in log₂-transformed biomarker levels.
Over a median follow-up of 6.3 (IQR: 5.9-6.7) years, 125 of 662 participants experienced the composite kidney endpoint, 58 participants died, 102 progressed in albuminuria and 94 developed a cardiovascular event. Higher baseline levels of PRO-C3 were associated with the development of the composite kidney endpoint (adjusted HR: 1.30, 95% CI 1.08-1.57, p < 0.01) and mortality (adjusted HR: 1.36, 95% CI 1.06-1.76, p = 0.016). No associations were found between PRO-C3 and albuminuria progression or cardiovascular events. PRO-C7, PRO-C28 and CTX-III were not associated with any of the endpoints.
Higher baseline serum PRO-C3, a marker of collagen type III formation and fibrogenesis, was associated with an increased risk of developing the composite kidney endpoint and all-cause mortality in individuals with type 1 diabetes.

PMID:
42322163
Bibliographic data and abstract were imported from PubMed on 20 Jun 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.